Impact of patient sex and dual antiplatelet therapy duration on 10-year mortality following percutaneous coronary intervention with drug-eluting stents: A post-hoc analysis of the ISAR-SAFE trial.
- DOI
- 10.1016/j.carrev.2026.10.021
- Published
- 2026 Nov 2
- Container
- Cardiovascular revascularization medicine : including molecular interventions
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.carrev.2026.10.021,
title = {Impact of patient sex and dual antiplatelet therapy duration on 10-year mortality following percutaneous coronary intervention with drug-eluting stents: A post-hoc analysis of the ISAR-SAFE trial.},
author = {Immobile Molaro M and Mayer K and Simonetti F and Lahu D and Lickel ME and Li Y and von Merzljak B and Brennicke E and Laugwitz KL and Seyfarth M and Cassese S and Mashayekhi K and Bernlochner I and Kastrati A and Han Y and Xhepa E},
year = {2026},
journal = {Cardiovascular revascularization medicine : including molecular interventions},
doi = {10.1016/j.carrev.2026.10.021},
url = {https://doi.org/10.1016/j.carrev.2026.10.021}
}RIS
TY - JOUR TI - Impact of patient sex and dual antiplatelet therapy duration on 10-year mortality following percutaneous coronary intervention with drug-eluting stents: A post-hoc analysis of the ISAR-SAFE trial. AU - Immobile Molaro M AU - Mayer K AU - Simonetti F AU - Lahu D AU - Lickel ME AU - Li Y AU - von Merzljak B AU - Brennicke E AU - Laugwitz KL AU - Seyfarth M AU - Cassese S AU - Mashayekhi K AU - Bernlochner I AU - Kastrati A AU - Han Y AU - Xhepa E PY - 2026 JO - Cardiovascular revascularization medicine : including molecular interventions DO - 10.1016/j.carrev.2026.10.021 UR - https://doi.org/10.1016/j.carrev.2026.10.021 ER -
APA
M, I. M., K, M., F, S., D, L., ME, L., Y, L., B, V. M., E, B., KL, L., M, S., S, C., K, M., I, B., A, K., Y, H., & E, X. (2026). Impact of patient sex and dual antiplatelet therapy duration on 10-year mortality following percutaneous coronary intervention with drug-eluting stents: A post-hoc analysis of the ISAR-SAFE trial.. Cardiovascular revascularization medicine : including molecular interventions. https://doi.org/10.1016/j.carrev.2026.10.021
Source records
- pubmed · retrieved 2026-11-10T11:29:49.018Z